The Medical Letter (@MedicalLetter) header
The Medical Letter (@MedicalLetter) profile picture

A nonprofit organization that has been providing independent reviews of drugs and therapeutics since 1959. Funded solely by subscriptions and donations.

New Rochelle, NY
Joined February 2010
Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)Photo by The Medical Letter (@MedicalLetter)
It's Trivia Tuesday! This question is from our article Antiviral Drugs for Seasonal Influenza medicalletter.org/TML-articl… Answer: b Oseltamivir is FDA-approved for treatment of influenza in patients ≥2 weeks old.
27
Advance Release In Brief: New Warning for GLP-1 Receptor Agonists bit.ly/3WHxRUx
95
Weltruza — A Once-Monthly Subcutaneous Formulation of Olanzapine medicalletter.org/olanz768b
83
Two New Blood Tests for Alzheimer's Disease medicalletter.org/alzhei768a
144
It's Trivia Tuesday! This question is from our article 2026-2027 COVID-19 Vaccination medicalletter.org/TML-articl… Answer: d Other risk factors for severe COVID-19 include immunocompromising conditions, use of immunosuppressive drugs, and chronic lung, heart, kidney or liver disease.
94
Tavapadon (Juvmo) for Parkinson's Disease medicalletter.org/tavap767b
1
91
It's Trivia Tuesday! This question is from our article Seasonal Influenza Vaccination: 2026-2027 secure.medicalletter.org/TML… Answer: d Vaccination in July or August may result in suboptimal immunity before the end of the influenza season, especially in persons ≥65 years old.
80
Camizestrant (Etcamah) for Advanced Breast Cancer medicalletter.org/camiz766c
106
It's Trivia Tuesday! This question is from our article Once-Weekly Insulin Icodec (Awiqli) for Type 2 Diabetes medicalletter.org/icode764a Answer: a Insulin icodec has a duration of action of ≥7 days. Insulin degludec and insulin glargine U300 are administered once daily.
1
1
134
Tezepelumab (Tezspire) for Nasal Polyps medicalletter.org/tezep766b
1
1
202
It's Trivia Tuesday! This question is from our article Drugs for Acute Treatment of Migraine medicalletter.org/migr763a Answer: b Data on efficacy of butalbital in relieving migraine pain are limited, and use can lead to tolerance, dependence, and addiction.
112
Today is #WomenPharmacistDay and October is #NationalPharmacistMonth! Join us as we celebrate the significant gains that women have made in pharmacy and recognize the important contributions that women pharmacists make to deliver quality care to patients nationwide. #WPD
141
This #PAweek, we’re recognizing how #PAsGoBeyond for patients and communities. From prescribing medication to assisting in surgery to diagnosing illness, physician associates treat patients in every specialty and setting. @aapaorg
1
136
Advance Release In Brief: A New Indication for Finerenone (Kerendia) bit.ly/4AJu3S5
1
139
In Brief: A Cardiovascular Indication for Tirzepatide (Mounjaro) medicalletter.org/TML-articl…
1
155